Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 06-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 47,338 | 0 | 31,365 | 28,735 | 1,377 |
| Cost of Goods | 2,790 | 0 | 8,325 | 5,705 | 3,737 |
| Gross Profit | 44,548 | 0 | 23,040 | 23,030 | -2,360 |
| Operating Expenses | 30,415 | 0 | 13,376 | 17,671 | 12,166 |
| Operating Income | 14,923 | 0 | 9,989 | 6,064 | -13,789 |
| Interest Expense | 368 | 0 | 593 | 352 | 401 |
| Other Income | 487 | 0 | 25 | 117 | 187 |
| Pre-tax Income | 15,042 | 0 | 9,421 | 5,829 | -14,003 |
| Income Tax | 2,854 | 0 | 2,609 | 1,547 | -1,440 |
| Net Income Continuous | 12,188 | 0 | 6,812 | 4,282 | -12,563 |
| Minority Interests | 3,828 | 0 | 2,363 | 1,077 | -3,004 |
| Net Income | $8,360 | $0 | $4,449 | $3,205 | $-9,559 |
| EPS Basic Total Ops | 0.15 | N/A | 0.08 | 0.06 | -0.17 |
| EPS Basic Continuous Ops | 0.21 | N/A | 0.12 | 0.08 | -0.22 |
| EPS Diluted Total Ops | 0.14 | N/A | 0.08 | 0.06 | -0.17 |
| EPS Diluted Continuous Ops | 0.21 | N/A | 0.12 | 0.08 | -0.22 |
| EBITDA(a) | $16,175 | $0 | $10,955 | $7,287 | $-12,356 |